DSMM-II, NCT02288741: Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy |
|
|
| Completed | 3 | 549 | Europe | Anthracycline/dexamethasone-based induction chemotherapy, ID, VAD, CAD, Dexamethasone for control of symptoms, dexamethasone, Tumor-reduction chemotherapy and stem cell mobilization, IEV + G-CSF, Stem cell apheresis, SC-apheresis, Tandem high-dose chemotherapy (melphalan), Tandem melphalan, Autologous peripheral blood stem cell transplantation, PBSCT | WiSP Wissenschaftlicher Service Pharma GmbH | Multiple Myeloma | 09/12 | 09/12 | | |
NCT01611051: A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy |
|
|
| Completed | 3 | 330 | RoW | Drug: Pegylated rhG-CSF: 100µg/kg, Pegylated rhG-CSF: 6mg, rhG-CSF 5ug/kg/day | Jiangsu HengRui Medicine Co., Ltd. | Breast Cancer, Neutropenia, Febrile Neutropenia | 01/13 | | | |
